Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.43 |
| ▸ | GGH | Q92820 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 5/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 2/20 | 0.34 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6848 | 1.00 | TGFBR1 (0.43) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL20798046 | 1.00 | TGFBR1 (0.43) | TGFBR1GGHCA2CA4CA1 | |
| Calcium SCHEMBL5654876 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL13720890 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL13720235 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL13720886 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL13720237 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL5654860 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL10496242 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 | |
| SCHEMBL1254623 | 0.98 | TGFBR1 (0.42) | TGFBR1GGHCA2CA4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 32443 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-119215059-B | Application of dexserine phosphate in preparation of medicine for preventing and/or treating kidney injury | LANZHOU UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122081433-A | Cattle spleen-derived active peptide for promoting digestion and absorption of children and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122070942-A | Implant adhesive and preparation method and application thereof | 杭州源囊生物科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026102249-A1 | TNF RECEPTOR SUPERFAMILY AGONIST FUSION POLYPEPTIDES | ANKYRA THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260130830-A1 | BIOADHESIVE COMPOSITION | INSTITUT STRAUMANN AG (CH) | 2026-05-14 | — | — | US | claimed |
| CN-122005503-A | Ultrasonic response apoptosis bionic targeting nano-carrier delivery material and preparation method thereof | 暨南大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122004301-A | Composite bioactive peptide composition for improving joint injury and preparation method thereof | 石家庄藏诺药业股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260102536-A1 | BIOADHESIVE COMPOSITION | INSTITUT STRAUMANN AG (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719439-A1 | AMORPHOUS CALCIUM CARBONATE FOR PREVENTION AND TREATMENT OF MYOCARDIAL ISCHEMIA | Amorphical Ltd. (IL) | 2026-04-08 | — | — | EP | claimed |
| WO-1987007615-A1 | PHOSPHOPEPTIDES | THE UNIVERSITY OF MELBOURNE (AU) | 1987-12-17 | — | — | WO | claimed |
| EP-0167115-A2 | New derivatives of L-carnitine | MAGIS FARMACEUTICI S.P.A. (IT) | 1986-01-08 | — | — | EP | claimed |
| EP-0166055-A2 | Caries inhibition | THE UNIVERSITY OF MELBOURNE (AU) | 1986-01-02 | — | — | EP | claimed |
| US-4543439-A | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1985-09-24 | — | — | US | claimed |
| EP-0073210-A4 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1985-06-10 | — | — | EP | claimed |
| US-4427762-A | DEVELOPMENT WITH ALKALINE DEVELOPER MIXTURE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-01-24 | — | — | US | claimed |
| EP-0082015-A1 | Method of forming an image with a photographic cuprous halide material | KONICA CORPORATION (JP) | 1983-06-22 | — | — | EP | claimed |
| EP-0073210-A1 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1983-03-09 | — | — | EP | claimed |
| WO-1982003008-A1 | CARIES INHIBITION | REYNOLDS ERIC CHARLES | 1982-09-16 | — | — | WO | claimed |
| US-4138476-A | Plaque dispersing enzymes as oral therapeutic agents by molecular alteration | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1979-02-06 | — | — | US | claimed |